Subtype
Pancreatic Neoplasm
CI-CAN-00001356Explore in graph →
Non-malignant988 active trials8 approved drugs63 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001356Explore in graph →
Clinical trials
4,217 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01977066 | Exercise Intervention Study for Pancreatic Cancer Patients(SUPPORT) | completed | N/A | 65 | German Cancer Research CenterOTHER | 1 | Feb 27, 2017 | clinicaltrials |
| NCT01198821 | Gem-TABS in Unresectable Pancreatic Carcinoma | completed | Phase 1 | 8 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00944463 | Trial of Simvastatin and Gemcitabine in Pancreatic Cancer Patients | completed | Phase 2 | 106 | Samsung Medical CenterOTHER | 1 | Feb 17, 2017 | clinicaltrials |
| NCT00350142 | Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer | completed | Phase 2 | 20 | Albert KoongOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT02374411 | Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients | completed | — | 55 | Edward HospitalOTHER | 1 | Feb 8, 2017 | clinicaltrials |
| NCT00093782 | Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma | completed | Phase 2 | 36 | National Cancer Institute (NCI)NIH | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00957424 | Acceptability of Less Harmful Alternatives to Cigarettes | completed | N/A | 67 | Roswell Park Cancer InstituteOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT02109341 | Phase I/II Study to Evaluate Nab-paclitaxel in Substitution of CPT11 or Oxaliplatin in FOLFIRINOX Schedule as First Line Treatment in Metastatic Pancreatic Cancer(NabucCO) | completed | Phase 1 / Phase 2 | 148 | Gruppo Oncologico Italiano di Ricerca ClinicaOTHER | 1 | Feb 3, 2017 | clinicaltrials |
| NCT01401894 | Perception Prognosis, Goals of Treatment, and Communication | completed | — | 50 | Massachusetts General HospitalOTHER | 1 | Jan 31, 2017 | clinicaltrials |
| NCT00489671 | Urine Cadmium Levels in Predicting Pancreatic Cancer Risk in Patients With Chronic Pancreatitis | completed | — | 32 | Wake Forest University Health SciencesOTHER | 0 | Jan 19, 2017 | clinicaltrials |
| NCT03016637 | Pancreatic Core Biopsy Needle Study in Patients Suspected of Pancreatic Malignancy(PANCOBE) | completed | Phase 1 / Phase 2 | 40 | Odense University HospitalOTHER | 1 | Jan 11, 2017 | clinicaltrials |
| NCT00901680 | Creation of the BioBank, Early Detection and Discovery Biomarkers | completed | — | 3,028 | Corewell Health EastOTHER | 1 | Jan 6, 2017 | clinicaltrials |
| NCT02720666 | K-001 Treatment of Advanced Pancreatic Cancer: Clinical Trial of Monotherapy's Tolerability | completed | Phase 1 | 12 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Jan 6, 2017 | clinicaltrials |
| NCT00003049 | Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas | completed | Phase 3 | 100 | Mayo ClinicOTHER | 1 | Dec 22, 2016 | clinicaltrials |
| NCT00251355 | Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer | completed | Phase 1 | 40 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 20, 2016 | clinicaltrials |
| NCT00448838 | Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | N/A | 42 | University of MiamiOTHER | 1 | Dec 15, 2016 | clinicaltrials |
| NCT00112528 | Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 53 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 13, 2016 | clinicaltrials |
| NCT00966277 | Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients | completed | Phase 4 | 87 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 12, 2016 | clinicaltrials |
| NCT02988635 | Early Palliative Care on Quality of Life of Advanced Cancer Patients | completed | Phase 3 | 281 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 0 | Dec 9, 2016 | clinicaltrials |
| NCT00059826 | Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer | completed | Phase 2 | 89 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 7, 2016 | clinicaltrials |
| NCT02984501 | Study of Induction Chemotherapy Followed by Radiochemotherapy in Locally Advanced Pancreatic Cancer | completed | Phase 2 | 41 | Campus Bio-Medico UniversityOTHER | 0 | Dec 7, 2016 | clinicaltrials |
| NCT02977702 | Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma | completed | — | 114 | Institut de Cancérologie de LorraineOTHER | 0 | Nov 30, 2016 | clinicaltrials |
| NCT01947166 | Pancreatic Resection, Malnutrition and Readmission | completed | N/A | 38 | Duke UniversityOTHER | 1 | Nov 29, 2016 | clinicaltrials |
| NCT01369420 | NanoKnife Low Energy Direct Current (LEDC) System in Subjects With Locally Advanced Unresectable Pancreatic Cancer | completed | Phase 2 | 10 | Angiodynamics, Inc.INDUSTRY | 1 | Nov 8, 2016 | clinicaltrials |
| NCT02565641 | A Study of Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 63 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01041612 | Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi | completed | Phase 4 | 120 | Taewoong Medical Co., Ltd.INDUSTRY | 2 | Oct 21, 2016 | clinicaltrials |
| NCT00499486 | Sirolimus in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 47 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 19, 2016 | clinicaltrials |
| NCT00804336 | Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors | completed | Phase 1 | 22 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 19, 2016 | clinicaltrials |
| NCT01661114 | A Trial of Gemcitabine, Infusional 5-Fluorouracil and Cisplatin for Advanced Pancreatic and Biliary Cancers | completed | Phase 2 | 39 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 19, 2016 | clinicaltrials |
| NCT00841607 | Reconstruction Following Pancreaticoduodenectomy: A Randomized Clinical Trial of Pancreaticojejunostomy vs Pancreaticogastomy | completed | N/A | 162 | Tom Baker Cancer CentreOTHER | 1 | Oct 18, 2016 | clinicaltrials |
| NCT00260364 | Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic Cancer(TARGET) | completed | Phase 1 / Phase 2 | 44 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 14, 2016 | clinicaltrials |
| NCT01384253 | Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy | completed | Phase 1 | 18 | Orano Med LLCINDUSTRY | 1 | Sep 30, 2016 | clinicaltrials |
| NCT01521325 | A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers | completed | Phase 1 | 6 | MorphotekINDUSTRY | 1 | Sep 30, 2016 | clinicaltrials |
| NCT00310115 | Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy | completed | — | 469 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 23, 2016 | clinicaltrials |
| NCT02909296 | Endoscopic Drainage of Collections After Pancreatic Surgery(COLLECTOR) | completed | — | 40 | Institut Paoli-CalmettesOTHER | 0 | Sep 21, 2016 | clinicaltrials |
| NCT01413022 | FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma | completed | Phase 1 | 44 | Washington University School of MedicineOTHER | 1 | Sep 19, 2016 | clinicaltrials |
| NCT02900950 | Multicolour Versus Monocolour Specimens Inking After Pancreaticoduodenectomy for Periampullary Cancer(MPM) | completed | N/A | 68 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Sep 15, 2016 | clinicaltrials |
| NCT01094561 | Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic Patients | completed | N/A | 23 | Elizabeth HechtOTHER | 1 | Sep 9, 2016 | clinicaltrials |
| NCT02150135 | Effect of Oncothermia on Improvement of Quality of Life in Unresectable Pancreatic Cancer Patients | completed | Phase 1 | 10 | Seoul National University HospitalOTHER | 1 | Sep 7, 2016 | clinicaltrials |
| NCT01935453 | A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer | completed | Phase 1 | 18 | OrienGene Biotechnology Ltd.INDUSTRY | 1 | Sep 1, 2016 | clinicaltrials |
| NCT00681798 | Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma | completed | Phase 1 | 8 | SanofiINDUSTRY | 1 | Aug 29, 2016 | clinicaltrials |
| NCT01488552 | Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 60 | Pancreatic Cancer Research TeamOTHER | 1 | Aug 18, 2016 | clinicaltrials |
| NCT00588640 | Study of D-Methadone in Patients With Chronic Pain | completed | Phase 1 / Phase 2 | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT01304160 | Role of Cyberknife Stereotactic Radiation Therapy (SBRT) Followed by Gemcitabine for Patients With Locally Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 10 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Aug 5, 2016 | clinicaltrials |
| NCT01360853 | Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer(ONTRAC) | completed | Phase 3 | 160 | Traws Pharma, Inc.INDUSTRY | 5 | Aug 4, 2016 | clinicaltrials |
| NCT00614653 | Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer | completed | Phase 1 | 17 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2016 | clinicaltrials |
| NCT00882310 | A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer | completed | Phase 2 | 37 | Columbia UniversityOTHER | 0 | Jul 25, 2016 | clinicaltrials |
| NCT00996333 | Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB) | completed | Phase 2 | 46 | Columbia UniversityOTHER | 1 | Jul 25, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Feb 27, 2017source: clinicaltrials